Notify me when PharVision Advisers, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 654 | $178M | +$158M | -$49.6M | +$108M | W, EXLS, TIGR, ARRY, SFM | 13F-HR | 11/14/2025, 05:32 PM |
| Q2 2025 | 267 | $69.6M | +$52.8M | -$56.2M | -$3.37M | EXLS, META, CRUS, MNST, VEEV | 13F-HR | 8/13/2025, 02:15 PM |
| Q1 2025 | 259 | $72.1M | +$49.7M | -$94.7M | -$45.1M | EXLS, ADSK, QCOM, NVGS, GSL | 13F-HR | 5/15/2025, 12:50 PM |
| Q4 2024 | 380 | $118M | $0 | $0 | EXLS, VZ, CSGS, CXW, NFLX | 13F-HR | 2/14/2025, 05:51 PM |